Literature DB >> 15075784

Colorectal cancer screening programme by faecal occult blood test in Tuscany: first round results.

G Grazzini1, G Castiglione, C Ciabattoni, F Franceschini, D Giorgi, S Gozzi, P Mantellini, P Lopane, M Perco, T Rubeca, P Salvadori, C B Visioli, M Zappa.   

Abstract

Screening with faecal occult blood test (FOBT) has been shown to be effective in reducing mortality from colorectal cancer. Tuscany was the first region in Italy in which a screening programme for colorectal cancer by FOBT was initiated region-wide. The aim of the paper was to describe organizational aspects, a quality control model and the results of this experience. From June 2000 to December 2001, 192583 subjects aged 50-70 were invited to undergo a 1-day immunochemical test without any dietary restriction. A total of 78505 subjects (41%) performed the screening test, of whom 4537 responders had a positive test result (5.8%). Among them, 1122 refused any form of assessment or underwent a colonoscopy outside the screening referral centres, with an overall assessment compliance of 75.3%. Malignancies were found in 193 patients and at least a high-risk adenomatous polyp in 692 patients. In about a quarter of the positive subjects who underwent assessment, cancer or high-risk adenoma was detected. In conclusion, data from this experience supported the feasibility of biennial colorectal screening programme by FOBT, particularly regarding invitation compliance and positivity rate. Further efforts are necessary to implement screening extension and to improve data collection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15075784     DOI: 10.1097/00008469-200402000-00004

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  19 in total

1.  Performance of the fecal immunochemical test is not decreased by high ambient temperature in the rapid return system.

Authors:  Jae Myung Cha; Joung Il Lee; Kwang Ro Joo; Hyun Phil Shin; Jae Jun Park; Jung Won Jeun; Jun Uk Lim; Sang-Hyun Hwang
Journal:  Dig Dis Sci       Date:  2012-03-27       Impact factor: 3.199

2.  CT colonography before colonoscopy in subjects with positive faecal occult blood test. Preliminary experience.

Authors:  L Sali; M Falchini; P Della Monica; D Regge; A G Bonanomi; G Castiglione; G Grazzini; M Zappa; F Mungai; C Volpe; M Mascalchi
Journal:  Radiol Med       Date:  2010-07-31       Impact factor: 3.469

3.  Colorectal cancer screening coverage in Greece. PACMeR 02.01 study collaboration.

Authors:  Konstantinos Kamposioras; Davide Mauri; Vassilis Golfinopoulos; Georgios Ferentinos; Georgios Zacharias; Apostolos Xilomenos; Nikolaos P Polyzos; Magdalini Bristianou; Dimitra Chasioti; Athanasios Milousis; Angeliki Vittoraki; Georgios Koukourakis; Ioanna Chatziioannou; Panagiotis Papadopoulos
Journal:  Int J Colorectal Dis       Date:  2006-08-29       Impact factor: 2.571

4.  CT colonography after incomplete colonoscopy in subjects with positive faecal occult blood test.

Authors:  Lapo Sali; Massimo Falchini; Andrea-Giovanni Bonanomi; Guido Castiglione; Stefano Ciatto; Paola Mantellini; Francesco Mungai; Ilario Menchi; Natale Villari; Mario Mascalchi
Journal:  World J Gastroenterol       Date:  2008-07-28       Impact factor: 5.742

5.  A comparative study of faecal occult blood kits in a colorectal cancer screening program in a cohort of healthy construction workers.

Authors:  M Shuhaibar; C Walsh; F Lindsay; N Lee; P Walsh; P O'Gorman; G Boran; R McLoughlin; A Qasim; N Breslin; B Ryan; H O'Connor; C O'Morain
Journal:  Ir J Med Sci       Date:  2010-10-17       Impact factor: 1.568

6.  Endoscopic follow-up of positive fecal occult blood testing in the Ontario FOBT Project.

Authors:  Lawrence Paszat; Linda Rabeneck; Lori Kiefer; Verna Mai; Paul Ritvo; Terry Sullivan
Journal:  Can J Gastroenterol       Date:  2007-06       Impact factor: 3.522

7.  Is Travel Time to Colonoscopy Associated With Late-Stage Colorectal Cancer Among Medicare Beneficiaries in Iowa?

Authors:  Mary E Charlton; Kevin A Matthews; Anne Gaglioti; Camden Bay; Bradley D McDowell; Marcia M Ward; Barcey T Levy
Journal:  J Rural Health       Date:  2015-11-26       Impact factor: 4.333

8.  Use of a low cut-off value for the fecal immunochemical test enables better detection of proximal neoplasia.

Authors:  Jae Myung Cha; Joung Il Lee; Kwang Ro Joo; Hyun Phil Shin; Jung Won Jeun; Jun Uk Lim
Journal:  Dig Dis Sci       Date:  2013-08-04       Impact factor: 3.199

9.  Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels.

Authors:  L Hol; J A Wilschut; M van Ballegooijen; A J van Vuuren; H van der Valk; J C I Y Reijerink; A C M van der Togt; E J Kuipers; J D F Habbema; M E van Leerdam
Journal:  Br J Cancer       Date:  2009-04-07       Impact factor: 7.640

10.  Cutoff value determines the performance of a semi-quantitative immunochemical faecal occult blood test in a colorectal cancer screening programme.

Authors:  L G M van Rossum; A F van Rijn; R J F Laheij; M G H van Oijen; P Fockens; J B M J Jansen; A L M Verbeek; E Dekker
Journal:  Br J Cancer       Date:  2009-09-15       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.